LIMES Schlosskliniken AG/€LIK
1D1W1MYTD1Y5YMAX
Capital at risk
About LIMES Schlosskliniken AG
LIMES Schlosskliniken AG operates private clinics specializing in the treatment of stress-related illnesses, mental, and emotional disorders, including depression, affective disorders, and acute burnout conditions. The company offers services primarily to private patients, those entitled to subsidies, and self-payers. Headquartered in Cologne, Germany, LIMES Schlosskliniken has expanded its geographic footprint through acquisitions, such as a 51% stake in Liechtenstein's Clinicum Alpinum AG in 2023, and increasing its stake in Switzerland's PRC Group AG to 56% in the same year. (,) In June 2025, the company opened LIMES Schlossklinik Abtsee, a specialized clinic for young adults aged 14 to 21, located near Salzburg, Austria. This strategic expansion enhances the company's service offerings and international presence.
- Ticker
- €LIK
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 314
- Headquarters
- Cologne, Germany
- Website
- www.limes-schlosskliniken.de
LIK Metrics
BasicAdvanced
€158M
28.91
€18.33
0.88
€10.00
1.89%
Price and volume
Market cap
€158M
Beta
0.88
52-week high
€605.00
52-week low
€300.00
Average daily volume
90
Dividend rate
€10.00
Financial strength
Current ratio
3.131
Quick ratio
2.928
Long term debt to equity
0.338
Total debt to equity
0.338
Interest coverage (TTM)
22.57%
Profitability
EBITDA (TTM)
13.532
Gross margin (TTM)
45.34%
Net profit margin (TTM)
9.71%
Operating margin (TTM)
16.64%
Effective tax rate (TTM)
24.17%
Revenue per employee (TTM)
€180,000
Management effectiveness
Return on assets (TTM)
13.54%
Return on equity (TTM)
27.67%
Valuation
Price to earnings (TTM)
28.91
Price to revenue (TTM)
2.807
Price to book
6.48
Price to tangible book (TTM)
8.82
Price to free cash flow (TTM)
23.439
Free cash flow yield (TTM)
4.27%
Free cash flow per share (TTM)
22.612
Dividend yield (TTM)
1.89%
Forward dividend yield
1.89%
Growth
Revenue change (TTM)
35.46%
Earnings per share change (TTM)
16.92%
3-year revenue growth (CAGR)
24.33%
3-year earnings per share growth (CAGR)
18.35%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.